Bioventus (BVS) FCF Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1,716.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,811.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,833.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 192.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 261.00 |
| 10 | Bioventus | 535.01 Mn | 544.52 Mn | 90.77 Mn | 2,208.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 2,208.00 |
| Dec 31, 2025 | 1,204.00 |
| Sep 27, 2025 | 1,515.00 |
| Jun 28, 2025 | 656.00 |
| Mar 29, 2025 | -1,085.00 |
| Dec 31, 2024 | 881.00 |
| Sep 28, 2024 | 955.00 |
| Jun 29, 2024 | 323.00 |
| Mar 30, 2024 | -396.00 |
| Dec 31, 2023 | -609.00 |
| Sep 30, 2023 | -90.00 |
| Jul 1, 2023 | 621.00 |
| Apr 1, 2023 | 1,955.00 |
| Dec 31, 2022 | 912.00 |
| Oct 1, 2022 | -1,275.00 |
| Jul 2, 2022 | -1,397.00 |
| Apr 2, 2022 | 329.00 |
| Dec 31, 2021 | -1,079.00 |
| Oct 2, 2021 | -1,044.00 |
| Jul 3, 2021 | 65.00 |
| Apr 3, 2021 | -4,585.00 |